Autoradiographic evidence for the effects of specific uptake-inhibitors on the selective accumulation of [3HJ-5-HT by supra-ependymal nerve terminals and for the localization of binding sites for [3H]-DLSD

BIRKMAYER, W., LINAUER, W., MENTASTI, M. & RIEDERER, P. (1974). Zweijahrige Erfahrungen einer Kombinationsbehandlung des Parkinson-syndroms mit L-dopa und dem Decarboxylasehemmer Benseracide (RO4-4602). Wien Med. Wochenschr., 124, 340-344. BIRKMAYER, W. & NEUMAYER, E. (1972). Die moderne medikamentose Behandlung des Parkinsonismus. Z. Neurol., 202, 257-280. BIRKMAYER, W., RIEDERER, P., YOUDIM, M.B.H. & LINAUER, W. (1975). The potentiation of the antiakinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil. J. Neurol. Trans., 36, 303-326. CHRISTMAS, A.J., COULSON, C.J., MAXWELL, D.R. & RIDDELL, D. (1972). A comparison of the pharmacological and biochemical properties of substrate-selective monoamine oxidase inhibitors. Br. J. Pharmac., 45, 490-503. FUXE, K. & UNGERSTEDT, U. (1970). Histochemical, biochemical and functional studies on central monoamine neurons after acute or chronic amphetamine administration. In Amphetamines and Related Compounds, eds. Costa, L. & Garattini, S., pp. 257-288. New York: Raven Press. KNOLL, J., ECSERI, Z., KELEMEN, K., NIEVEL, J. & KNOLL, B. (1965). Phenylisopropylmethyl propinylamine (E-250), a new spectrum psychic energizer. Arch. int. Pharmacodyn., 155, 154-164.

[1]  J. Richards,et al.  Ultrastructural evidence for the localization of an indolealkylamine in supra-ependymal nerves from combined cytochemistry and pharmacology , 1974, Experientia.

[2]  P. Riederer,et al.  The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil , 2005, Journal of Neural Transmission.

[3]  J. Richards,et al.  5-HT nerve terminals in the fourth ventricle of the rat brain: Their identification and distribution studied by fluorescence histochemistry and electron microscopy , 1975, Cell and Tissue Research.

[4]  J. Richards,et al.  Distribution of indolealkylamine nerve terminals in the ventricles of the rat brain , 1973, Zeitschrift für Zellforschung und Mikroskopische Anatomie.

[5]  E. Neumayer,et al.  Die moderne medikamentöse Behandlung des Parkinsonismus , 1972, Zeitschrift für Neurologie.

[6]  I. Creese,et al.  The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states. , 1975, Life sciences.

[7]  S. Snyder,et al.  Stereospecific binding ofd-lysergic acid diethylamide (LSD) to brain membranes: Relationship to serotonin receptors , 1975, Brain Research.

[8]  J. Richards,et al.  Indolealkylamine nerve terminals in cerebral ventricles: identification by electron microscopy and fluorescence histochemistry. , 1973, Brain research.

[9]  D. Riddell,et al.  A comparison of the pharmacological and biochemical properties of substrate‐selective monoamine oxidase inhibitors , 1972, British journal of pharmacology.

[10]  M. Vogt,et al.  Release of 5‐hydroxytryptamine from caudate nucleus and septum , 1972, The Journal of physiology.